• View Press Releases

    View Press Releases

News & Media

Recent News

View All News

Twitter

  • Thank you to all the campers who shared their personal #cancer stories and perspectives at @EpicXperience – you inspire us! · 12 hours ago
  • We’re spending time this week with an inspiring group of Hodgkin lymphoma survivors at @EpicXperience! · 5 days ago
 

Quick Facts

Year founded 1998

Public Company Nasdaq:SGEN

Number of Employees 1,300+

Global Headquarters Bothell, WA

European Office Zug, Switzerland

icon-sw.png

Approved Product ADCETRIS® (brentuximab vedotin)

adcetris.png

Disease Focus Areas Hodgkin lymphoma, non-Hodgkin lymphoma, urothelial cancer, breast cancer, cervical cancer

heart.png

ADC Collaborations Multiple ADC technology licensing agreements; co-development collaborations with other oncology industry leaders

Resources

Social Media

 

Media Contacts

For Media Professionals Only

Monique Greer, Vice President Corporate Communications

media@seagen.com